KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $7.9 million.

  • Oscar Health's Depreciation & Amortization (CF) fell 1456.73% to $7.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.9 million, marking a year-over-year decrease of 1009.49%. This contributed to the annual value of $28.9 million for FY2025, which is 1009.49% down from last year.
  • Oscar Health's Depreciation & Amortization (CF) amounted to $7.9 million in Q4 2025, which was down 1456.73% from $7.3 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Depreciation & Amortization (CF) peaked at $9.2 million during Q4 2024, and registered a low of $3.4 million during Q1 2021.
  • Over the past 5 years, Oscar Health's median Depreciation & Amortization (CF) value was $6.8 million (recorded in 2025), while the average stood at $6.1 million.
  • In the last 5 years, Oscar Health's Depreciation & Amortization (CF) skyrocketed by 13901.38% in 2023 and then plummeted by 1839.84% in 2024.
  • Oscar Health's Depreciation & Amortization (CF) (Quarter) stood at $4.0 million in 2021, then fell by 5.49% to $3.8 million in 2022, then skyrocketed by 106.5% to $7.7 million in 2023, then rose by 19.17% to $9.2 million in 2024, then decreased by 14.57% to $7.9 million in 2025.
  • Its last three reported values are $7.9 million in Q4 2025, $7.3 million for Q3 2025, and $7.0 million during Q2 2025.